These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26682865)

  • 21. Alignment: a conceptual shift from adherence.
    Selzer RM; Ellen S; McGartland M
    Intern Med J; 2013 Aug; 43(8):940-2. PubMed ID: 23919336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding the framework of assessing adherence and medication-taking behavior.
    Alsalman AJ; Smith WR
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):114-24. PubMed ID: 23621173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Education, psychology and 'compliance'.
    Price PE
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S101-5. PubMed ID: 18351625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug dosing in elderly patients with chronic kidney disease.
    Lassiter J; Bennett WM; Olyaei AJ
    Clin Geriatr Med; 2013 Aug; 29(3):657-705. PubMed ID: 23849014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adapting electronic adherence monitors to standard packages of topical medications.
    Tusa MG; Ladd M; Kaur M; Balkrishnan R; Feldman SR
    J Am Acad Dermatol; 2006 Nov; 55(5):886-7. PubMed ID: 17052499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical correlates of drugs in saliva.
    Wilson JT
    Ann N Y Acad Sci; 1993 Sep; 694():48-61. PubMed ID: 8215085
    [No Abstract]   [Full Text] [Related]  

  • 27. [Why measure drug metabolites?].
    Hendset M; Hermann M
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1786-8. PubMed ID: 17599129
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of workplace health services on adherence to chronic medications.
    Sherman BW; Frazee SG; Fabius RJ; Broome RA; Manfred JR; Davis JC
    Am J Manag Care; 2009 Jul; 15(7):e53-9. PubMed ID: 19589007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication compliance protocol for pediatric patients with severe intellectual and behavioral disabilities.
    Epitropakis C; DiPietro EA
    J Pediatr Nurs; 2015; 30(2):329-32. PubMed ID: 25193686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dosing frequency on chronic cardiovascular disease medication adherence.
    Coleman CI; Roberts MS; Sobieraj DM; Lee S; Alam T; Kaur R
    Curr Med Res Opin; 2012 May; 28(5):669-80. PubMed ID: 22429067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of adherence to headache treatments by means of hair analysis.
    Ferrari A; Licata M; Rustichelli C; Baraldi C; Vandelli D; Marchesi F; Palazzoli F; Verri P; Silingardi E
    Eur J Clin Pharmacol; 2017 Feb; 73(2):197-203. PubMed ID: 27866243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.
    Hermann MM; Papaconstantinou D; Muether PS; Georgopoulos G; Diestelhorst M
    Acta Ophthalmol; 2011 Jun; 89(4):e300-5. PubMed ID: 21106046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group.
    Krumholz HM; Currie PM; Riegel B; Phillips CO; Peterson ED; Smith R; Yancy CW; Faxon DP;
    Circulation; 2006 Sep; 114(13):1432-45. PubMed ID: 16952985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Descriptive tools and analysis.
    Capellà D
    WHO Reg Publ Eur Ser; 1993; 45():55-78. PubMed ID: 8442851
    [No Abstract]   [Full Text] [Related]  

  • 35. Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine.
    Scavone C; Sportiello L; Cimmaruta D; Sullo MG; Vitelli B; Rafaniello C; Fossati T; Rossi F
    Minerva Endocrinol; 2016 Jun; 41(2):279-89. PubMed ID: 27015567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving Bar Code Medication Administration Compliance in a Community Hospital Through a Nursing Leadership Initiative.
    Van Ornum M
    J Nurs Care Qual; 2018; 33(4):341-347. PubMed ID: 29319594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do we measure adherence to anti-tuberculosis treatment?
    Valencia S; León M; Losada I; Sequera VG; Fernández Quevedo M; García-Basteiro AL
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):157-165. PubMed ID: 27910715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which drug class and why?
    Shakib S; George A
    Aust Fam Physician; 2003 May; 32(5):325-8. PubMed ID: 12772364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.
    Lenti MV; Selinger CP
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):215-226. PubMed ID: 28099821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three benefit models improve specialty drug adherence.
    Kirkner RM
    Manag Care; 2014 Oct; 23(10):32-5. PubMed ID: 25945387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.